Back
Almirall SA (ALMRY) Price
ALMRY Stock Price Chart
ALMRY Earnings
Almirall SA
$12.76
0%
$0
At close: Feb 06, 16:00:00 GMT-5
$12.76
0%
$0
Pre-market: Feb 09, 07:54:46 GMT-5
Latest Earnings Results: Q2 '25
Reported: 2025-07-25
Historical Earnings
Quarterly
Annual
EPS
Revenue
Earnings FAQ
How did ALMRY's recent EPS compare to expectations?
How did Almirall SA ALMRY's revenue perform in the last quarter?
What is the revenue estimate for Almirall SA?
What's the earning quality score for Almirall SA?
When does Almirall SA report earnings?
What are Almirall SA's expected earnings?
Did Almirall SA beat earnings expectations?
Key Stats
Prev.Close
$12.76
Open
$9.86
Day's Range
$9.86 - $12.76
52 week range
$9.86 - $12.76
Volume
300
Avg.Volume
0
EPS (TTM)
0.23
Dividend yield
--
Market Cap
$2.7B
What is Almirall SA?
Almirall SA is a global biopharmaceutical company, which is focused on skin health. The company is headquartered in Barcelona, Barcelona and currently employs 2,084 full-time employees. The company went IPO on 2007-04-19. The firm focuses on development and marketing of drugs applied in various therapeutic areas, such as nervous system, gastrointestinal, dermatological, respiratory system, antiinfectives, as well as antineoplastic and immunomodulating agents. The firm's activities are divided into four business segments: Own network, which focuses on the commercialization of pharmaceuticals through own brand names; Licenses, which sells product rights to third parties; Research and development (R&D), which is responsible for the creation of drug candidates, as well as Dermatology, which includes sale of dermatological medicines in the United States. The firm operates through numerous subsidiaries in Europe, the Americas, Africa, Asia and Australia.
Features
Trading Strategies
Resources
© 2025 Finture Development Limited. All rights reserved